Literature DB >> 16467332

Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.

Hiroyuki Wakabayashi1, Natsuko Takakura, Koji Yamauchi, Yoshitaka Tamura.   

Abstract

Oral administration of lactoferrin (LF), an antimicrobial and immunomodulatory protein, shows a protective effect against infectious diseases, possibly via immunomodulation of the host. Initially, we confirmed an immunomodulatory effect of LF by observing changes in the number of cells in the leukocyte subsets in the peripheral blood and spleens of mice 1 day after oral administration of LF. Then we developed a quantitative reverse transcription-PCR method for 20 immunity-related genes of antimicrobial proteins, pattern recognition receptors, cytokines, and lymphocyte mobilization-related proteins, and we assessed the expression of these genes in the small intestines of mice 2 h after administration of water, bovine serum albumin (BSA), or LF. Expression of the LF gene was lower in mice administered LF than in mice administered water or BSA, implying a negative-feedback control. Expression of gamma interferon (IFN-gamma) and interleukin-10 (IL-10) was lower in both BSA- and LF-administered mice than in water administered mice, suggesting a nonspecific effect of protein ingestion. Expression of NOD2, IFN-beta, and IL-12p40 was higher with LF administration than with water or BSA administration. The expression levels of these three genes were correlated. This study indicated that oral administration of LF modulates the small intestinal expression of genes closely related to the host defense in a specific or a nonspecific manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467332      PMCID: PMC1391931          DOI: 10.1128/CVI.13.2.239-245.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  38 in total

Review 1.  Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process.

Authors:  S Baveye; E Elass; J Mazurier; G Spik; D Legrand
Journal:  Clin Chem Lab Med       Date:  1999-03       Impact factor: 3.694

2.  Lactoferrin given in food facilitates dermatophytosis cure in guinea pig models.

Authors:  H Wakabayashi; K Uchida; K Yamauchi; S Teraguchi; H Hayasawa; H Yamaguchi
Journal:  J Antimicrob Chemother       Date:  2000-10       Impact factor: 5.790

3.  Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Authors:  L A Håversen; I Engberg; L Baltzer; G Dolphin; L A Hanson; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium.

Authors:  T Kuhara; M Iigo; T Itoh; Y Ushida; K Sekine; N Terada; H Okamura; H Tsuda
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

5.  Peptide localization and gene structure of cryptdin 4, a differentially expressed mouse paneth cell alpha-defensin.

Authors:  A J Ouellette; D Darmoul; D Tran; K M Huttner; J Yuan; M E Selsted
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

7.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study.

Authors:  K Yamauchi; M Hiruma; N Yamazaki; H Wakabayashi; H Kuwata; S Teraguchi; H Hayasawa; N Suegara; H Yamaguchi
Journal:  Mycoses       Date:  2000       Impact factor: 4.377

9.  Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study.

Authors:  K Tanaka; M Ikeda; A Nozaki; N Kato; H Tsuda; S Saito; H Sekihara
Journal:  Jpn J Cancer Res       Date:  1999-04

10.  Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.

Authors:  W P Wang; M Iigo; J Sato; K Sekine; I Adachi; H Tsuda
Journal:  Jpn J Cancer Res       Date:  2000-10
View more
  15 in total

1.  Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.

Authors:  Kerry J Welsh; Shen-An Hwang; Sydney Boyd; Marian L Kruzel; Robert L Hunter; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2011-12-03       Impact factor: 3.131

2.  Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.

Authors:  Miriam Canavese; Andrea Crisanti
Journal:  Pathog Glob Health       Date:  2015-09-21       Impact factor: 2.894

3.  VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.

Authors:  Miriam Canavese; Tania Dottorini; Andrea Crisanti
Journal:  Pathog Glob Health       Date:  2015-09-21       Impact factor: 2.894

4.  Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Yogesh A Bangale; Marian L Kruzel; Jeffrey K Actor
Journal:  Med Microbiol Immunol       Date:  2007-03-22       Impact factor: 3.402

Review 5.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochimie       Date:  2008-04-27       Impact factor: 4.079

7.  Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.

Authors:  Shen-An Hwang; Katarzyna M Wilk; Monika Budnicka; Margaret Olsen; Yogesh A Bangale; Robert L Hunter; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2007-07-27       Impact factor: 3.641

8.  Lactoferrin Augmentation of the BCG Vaccine Leads to Increased Pulmonary Integrity.

Authors:  Shen-An Hwang; Kerry J Welsh; Marian L Kruzel; Jeffrey K Actor
Journal:  Tuberc Res Treat       Date:  2011-04-28

9.  Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.

Authors:  Jason R Lees; Paul T Golumbek; Julia Sim; Denise Dorsey; John H Russell
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

10.  Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial.

Authors:  Nancy A Rodriguez; Maximo Vento; Erika C Claud; Chihsiung E Wang; Michael S Caplan
Journal:  Trials       Date:  2015-10-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.